Explore our core turnkey capabilities covering end-to-end preclinical validation, phytocompound potency mapping, analytical chemistry standards, and GMP-grade custom dosage manufacturing.
Statistically powered, GCP-compliant human clinical trials for dietary supplements and botanical drug candidates substantiate structural and functional efficacy claims.
Explore Study Protocols
Multi-origin botanical bioactive mapping to pinpoint geographic chemotypes, seasonal harvest windows, and organ-specific yield optimization for superior potency.
Review Origin Mapping
High-throughput cellular modeling, enzyme kinetics, receptor-binding assays, and cytotoxicity screening providing rapid, data-backed go/no-go formulation decisions.
Examine In Vitro Assays
ICH Q2(R1) method validation covering HPLC, HPTLC, GC-MS, and chromatographic fingerprinting to verify botanical identity, assay purity, and batch stability.
View QC Specifications
Target-directed extraction and purification of bio-functional polysaccharides, alkaloids, and flavonoids from exotic botanical taxa for proprietary functional claims.
Access Screening Library
GLP-accredited animal models evaluating bioavailability, dose-response curves, metabolic pathways, and systemic safety markers (acute and sub-chronic toxicity).
Review Animal Studies
Industrial-scale continuous countercurrent extraction yielding standardized powders, paste concentrates, and volatile lipophilic extracts with certified active titration.
Request Extract Specs
Complete formulation engineering for two-piece vegetarian capsules, softgels, micro-tablets, effervescent powders, and sterile oral liquids under cGMP conditions.
Explore Dosage OptionsThe global dietary supplement marketplace is experiencing a fundamental paradigm shift. The historical contract manufacturing model—dominated by white-label packaging, untraced botanical commodities, and decorative "fairy-dusting" of active compounds—is being dismantled by stricter regulatory enforcement, heightened consumer literacy, and competitive margin pressures. Modern health and wellness brand operators can no longer build sustained equity on unsubstantiated marketing declarations. Real market authority demands verifiable chemical profiles, reproducible bio-availability, certified safety toxicity baselines, and human clinical trial validation.
Headquartered in the biopharmaceutical innovation hub of Changsha, Hunan, China, MedGence Technical Co., Ltd. (Yineng Pharma) operates as a dual-engine Contract Research Organization (CRO) and Contract Development & Manufacturing Organization (CDMO). Backed by more than 14 years of rigorous phytopharmaceutical exploration and an elite team of 300+ multidisciplinary scientists, we have executed comprehensive R&D mandates for more than 100 prominent pharmaceutical corporations, tertiary university hospitals, and international supplement brands. Our specialized capabilities encompass the modernization of 83 classic Traditional Chinese Medicine (TCM) formulas, the commercialization of 22 novel natural chemical drug candidates, 56 registered hospital-grade medicinal preparations, and the codification of nearly 400 single-herb analytical standards. We empower global brands to transform complex botanical matrices into patentable, clinically substantiated, and shelf-stable ODM dietary supplements.
Our development pipelines comply stringently with ICH guidelines, US FDA 21 CFR Part 111 cGMP regulations, and ISO/IEC 17025 laboratory standards, guaranteeing unshakeable evidentiary integrity.
We deconstruct polyherbal synergies via high-resolution Q-TOF-MS and 2D-LC, isolating targeted active markers (e.g., ginsenosides, icariin, berberine, polysaccharides) for exact stoichiometric consistency.
Client formulations, specialized extraction parameters, and proprietary enzymatic steps operate under confidential contract research models with guaranteed non-disclosure protection.
Valued at over USD 178 billion in 2024 and projected to expand at an 8.9% CAGR through 2032, the dietary supplement market is navigating intense geopolitical realignments, raw material volatility, and escalating technical hurdles.
Agricultural volatility driven by climate shifts has generated severe variance in botanical secondary metabolites. Unstandardized crude powders fluctuate up to 400% in therapeutic phytochemical concentration depending on rainfall, soil composition, and harvest timing. MedGence solves this instability via multi-origin chemotypic screening and seasonal potency audits, guaranteeing precise titer standardization regardless of climatic disruption.
Disparate regional regulations—ranging from the US DSHEA structure/function framework to the EU EFSA strict botanical health claim authorization under Article 13/14—demand customized dossiers. MedGence equips ODM clients with dual-tier regulatory data packages: complete chromatographic fingerprint profiles for North America and fully documented safety/toxicology dossiers ready for European Novel Food evaluations.
Traditional crude botanical extracts suffer from abysmal oral bioavailability due to gastrointestinal degradation, poor aqueous solubility, and rapid hepatic clearance. The modern ODM battlefield is won through drug-delivery science: self-emulsifying drug delivery systems (SEDDS), phytosome conjugation, and pH-dependent enteric release mechanisms that optimize therapeutic plasma levels.
A single universal formulation cannot succeed across structurally divergent consumer cultures and statutory jurisdictions. We engineer localized ODM solutions calibrated to regional consumer behaviors, delivery form preferences, and legal thresholds.
Regulatory Standard: FDA 21 CFR 111, DSHEA, Health Canada NPN.
Consumer Driver: High-potency single-actives, clean-label transparency, cognitive nootropics, metabolic balance, and non-GMO vegan verification.
ODM Engineering: Liquid-filled hard capsules, beadlet-in-oil delivery, rapid-dissolve plant pectin gummies, and standardized botanical extracts with complete pesticide/heavy metal residual documentation (USP <561> compliance).
Regulatory Standard: Directive 2002/46/EC, EFSA Novel Foods, EMA Herbal Monographs.
Consumer Driver: Preventive wellness, natural botanicals with traditional medicinal evidence, micro-dosing adaptogens, and recyclable eco-packaging.
ODM Engineering: Pharmaceutical-grade blistered plant cellulose capsules, dry powder ampoules, standardized aqueous extracts free of ethylene oxide (EtO), polycyclic aromatic hydrocarbons (PAHs), and pyrrolizidine alkaloids.
Regulatory Standard: China SAMR "Blue Hat", Japan FFC (Foods with Function Claims), Australia TGA (AUST-L).
Consumer Driver: Modernized Traditional Chinese Medicine, functional longevity tonics, inner-beauty oral collagen-botanical concentrates, and hepatoprotective formulations.
ODM Engineering: High-density liquid oral stick-packs, softgels with nano-dispersions, effervescent granules, and micro-molecular fermented herbal teas with pleasant organoleptic profiles.
The boundaries separating pharmaceutical drugs and preventative dietary supplements are dissolving. Our strategic R&D roadmap outlines the technological progression governing natural medicine manufacturing over the coming decade.
Deployment of machine-learning models predicting plant multi-target pharmacology (polypharmacology) and affinity binding before bench synthesis.
Transition from batch processing to continuous micro-fluidic extraction and closed-loop supercritical fluid fractionation with zero solvent waste.
Next-generation targeted delivery systems protecting delicate actives through gastric acid transit for site-specific gut absorption.
Enzymatic bio-transformation and precision cellular fermentation of rare botanical actives that cannot be ecologically wildcrafted.
Fragmented contracting between botanical brokers, testing laboratories, clinical outfits, and contract packaging factories inevitably causes data disconnects, IP leakages, and batch failure. MedGence integrates every stage under a unified, accountable management hierarchy.
We identify candidate bioactive molecules aligned with target commercial claims, screening regional botanical populations across seasons, altitudes, and plant anatomies (root, stem, leaf, seed) to maximize yields.
Deliverable: Phytochemical Profiling DossierOur analytical teams establish and validate proprietary HPLC, HPTLC, and GC-MS testing methods, producing certified chromatographic fingerprints that guarantee raw material authenticity and batch-to-batch homogeneity.
Deliverable: Validated QC Assay MonographExtraction kinetics, column adsorption resin parameters, crystallization protocols, and spray-drying temperature profiles are mapped at pilot scale to protect active heat-sensitive compounds and establish cost-efficient yields.
Deliverable: Pilot Batch Manufacturing RecordWe carry out GLP-compliant LD50 evaluations, 90-day sub-chronic oral toxicity studies, Ames bacterial mutagenicity tests, and cell-based biological assays to establish uncompromising human safety margins.
Deliverable: Safety & Toxicology PortfolioDouble-blind, placebo-controlled human studies or small-group dietary supplement cohort evaluations substantiating physiological endpoints (e.g., glycemic response, lipid profile, cognitive function, joint mobility).
Deliverable: Peer-Reviewable Clinical Study DataCommercial-scale production of finished dosage formats (capsules, tablets, softgels, liquid vials, or bulk active concentrates) in cleanrooms compliant with cGMP 21 CFR 111, packaged for global multi-channel delivery.
Deliverable: Release-Certified Commercial BatchesOur scientific methodologies and manufacturing lines are rigorously validated by collaborations with China's foremost state pharmaceutical groups, listed biotechs, and prestigious clinical research hospitals.
Tongrentang Group
CR Sanjiu Pharma
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtze River Pharma
Gofar Chuanshan
Humanwell Healthcare
SCIMYTH Pharma
Hanfang Pharma
Luoxin Pharma
Zhongsheng Pharma
Brilliance & Abundance
Apeloa Pharma
Heng Chang Pharma
Baotou TCM
Kamp Medicine
Santo Pharma
Kangshou Pharma
Juwang Pharma
Tcmages Pharma
Ruihe Pharma
CR Jinchan Pharma
Kangmei Pharma
Tianjicaotang Pharma
Kingstone Unite
Shuguang Hospital TCM
Hunan Direct TCM Hosp.
1st Hosp. Hunan TCM
2nd Xiangya Hospital
2nd Hosp. Hunan TCM
Zhuzhou Orthopedics TCM
Direct, transparent answers addressing regulatory substantiation, analytical methods, IP protection, minimum order volumes, and clinical design.
Explore our active portfolio ready for rapid OEM license, pilot transfer, or custom ODM formulation refinement.
Comprehensive human trial infrastructure with biomarker tracking, institutional review board approvals, and statistical clinical reporting.
Access Study Assets
Multi-variable seasonal potency quantification identifying peak harvesting windows to maximize concentration of therapeutic phytochemicals.
Request Potency Audit
Primary cell cultures and continuous cell line testing platforms evaluating glucose uptake, anti-inflammatory cascades, and oxidative stress reduction.
View Assay Protocols
Establishment of HPLC, HPTLC, and GC-MS standard operating procedures to verify chemical fingerprint identity and rule out adulteration.
Download Testing Guide
Rapid identification of bio-functional small molecules, polyphenols, and adaptogenic saponins tailored for cognitive and longevity formulations.
Request Phytochemical Data
Standardized in vivo models for bioavailability verification, systemic toxicity tracking, and organ-level histopathology assessments.
Examine In Vivo Data
Ultra-purified standardized herbal extracts in vacuum-dried powders, spray-dried granules, and concentrated pastes for global formulation integration.
Request Sample Batches
Full cGMP commercial development for hard capsules, softgels, micro-tablets, oral liquid shots, and effervescent drink powders.
Schedule Production RunCollaborate directly with our principal analytical chemists and pharmacologists. Send your targeted health claim, active botanical concept, or desired dosage form to obtain a full study scope, feasibility analysis, and commercial manufacturing proposal.
